I formulated the missing-self hypothesis for natural killer (NK) cell recognition in the autumn of 1981, while writing the last chapter of my doctoral thesis. In 1975, I had joined the Department ...

Creating cancer therapies based around natural killer cells could offer similar levels of efficacy to CAR-T therapies, but at around one hundredth of the cost. Researchers at MD Anderson Cancer ...

The partnership is set to leverage Cellistic's 3D bioreactor-based ... stem cell (iPSC)-derived B-cell maturation antigen (BCMA)-targeting CAR-natural killer T (NKT) cells for Phase I trials ...